The Karyopharm Therapeutics brand, founded in 2008 (United States), from 5 sister brands and 2214 competing brands. The Karyopharm Therapeutics brand is owned by Karyopharm Therapeutics, a company listed in New York. Karyopharm Therapeutics belongs to the Biotechnology business sector.
Investment simulator :
Portfolio valuation
Karyopharm Therapeutics
over 5 years*
USD 0.25